Whats new
Whats new.
Maxim Group - Positive Survival Data for Efti + Keytruda in 1L Lung Cancer at ESMO; Sets Stage for P3 Study in CY24; Mtn Buy, $10 tgt (Jason McCarthy, PhD)
October 23rd 2023
For a copy of this analyst report please contact your Maxim advisor